Moderna Financial Health
How is Moderna's financial position?
[object Object] Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: MRNA's short term assets ($14.3B) exceed its short term liabilities ($6.8B).
Long Term Liabilities: MRNA's short term assets ($14.3B) exceed its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: MRNA is debt free.
Reducing Debt: MRNA has no debt compared to 5 years ago when its debt to equity ratio was 2.2%.
Debt Coverage: MRNA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MRNA has no debt, therefore coverage of interest payments is not a concern.